| Alan H. Auerbach | President and Chief Executive Officer | FY2025 | |
| Jeff J. Ludwig | Chief Commercial Officer | FY2025 | |
| Maximo F. Nougues | Chief Financial Officer | FY2025 | |
| Douglas Hunt, B.Sc (Hons) | Chief Regulatory Affairs, Medical Affairs, and Pharmacovigilance Officer | FY2025 |
4 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.